The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson’s Disease
OXFORD, England and KRAKOW, Poland, June 5, 2023 /PRNewswire/ — The University of Oxford and Selvita (WSE: SLV), one of the largest contract research organizations in Europe, announced an integrated drug discovery collaboration in the area of Parkinson’s disease. While Parkinson’s disease is the second most common neurodegenerative disease affecting ~7 million people worldwide, there … Read more